Repligen
Repligen | Inspiring Advances in Bioprocessing.
HQ location
Waltham, United States
Website
Launch date
Employees
Market cap
$6.7b
Enterprise value
$6.7b
Share price
$122.17 RGEN
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $600m | Post IPO Convertible |
| Total Funding | 000k | ||
No items found
No investors found
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 83 % | 20 % | (20 %) | (1 %) | 15 % | 14 % | 17 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 26 % | 23 % | 14 % | 8 % | 20 % | 21 % | 24 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 19 % | 23 % | 7 % | (4 %) | 7 % | 9 % | 12 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 5 % | 5 % | 7 % | 7 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Repligen
Edit
ACQUISITION by Repligen Jul 2024
ACQUISITION by Repligen Dec 2016
ACQUISITION by Repligen Jun 2017
ACQUISITION by Repligen Apr 2016
ACQUISITION by Repligen Sep 2021
ACQUISITION by Repligen Nov 2020
ACQUISITION by Repligen Sep 2023
ACQUISITION by Repligen Jun 2021